The Nuffield Department of Clinical Medicine is part of the Medical Sciences Division. It hosts one of the largest groupings of Biomedical Researchers in the University Sector, and is also responsible for a significant part of the teaching of clinical medical students with the Oxford Medical School.
Sign up for this workshop on H2020 challenges and opportunities. Come along to see how you and your research can benefit and how changes in approach may be needed to capitalise on current EU funding as well as shape the content of future calls. The workshop is held on Monday 16th Dec at 2pm in Rooms A/B in the Wellcome Trust Centre for Human Genetics.
The four year NDM Prize Studentships are our principal fully-funded awards and are open to outstanding candidates from any country without restriction. Applications are currently being accepted for the October 2014 start. The closing date for applications is 10th January 2014.
NDM’s recently granted Athena SWAN Bronze Award was formally presented to the Department by Dame Julia Higgins FRS FREng, at a ceremony hosted by Imperial College, London on Nov 7th, 2013. Professors Peter Ratcliffe and Xin Lu were present to receive the award on behalf of NDM. Professor Ratcliffe stated the importance of retaining and developing diversity in the Department, “the inspiration, support, mentorship, career development, and ...
Dr Ellie Barnes delighted researchers at the Wellcome Trust Centre for Human Genetics’ recent Women in Science talk, held on Wednesday the 20th of November. Her presentation entitled: Women in Science – the joys and the juggles, highlighted the ups and downs of balancing a career in science, particularly as a working mother.
A hepatologist and academic, a wife and a mother of two, Dr Barnes said that while it is often difficult to juggle everything, it’s ultimately worth it.
Putting drug discovery back on target
Interview with Chas Bountra and Peter Ratcliffe.
'The world urgently needs new medicines for many diseases', says Professor Chas Bountra, 'the fundamental bottleneck is our ability to identify new targets for drug discovery.' Professor Peter Ratcliffe is of exactly the same mind: 'In starting drug development you need to start in the right place. We need to have the right molecular target.' The new Target Discovery Institute aims to validate targets for drug discovery.
Read the University Science Blog